Immunic
IMUX
32 hedge funds and large institutions have $67.1M invested in Immunic in 2014 Q2 according to their latest regulatory filings, with 32 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$21.9M |
| 2 |
RIM
RS Investment Management
San Francisco,
California
|
+$10M |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$2.23M |
| 4 |
Goldman Sachs
New York
|
+$1.64M |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$828K |
Top Sellers
IMUX Hedge Fund Activity: Q2 2014 in Review
32 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Immunic (IMUX) for Q2 2014, worth a combined $67.1M.
Buyers outnumbered sellers: 32 funds opened new IMUX positions and 0 closed out — a net gain of 32 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Fidelity Investments, opening a new position worth an estimated $21.9M.
- 32 institutional investors held Immunic (IMUX) as of Q2 2014, up from 0 in Q1 2014.
- Funds reported $67.1M of Immunic stock for Q2 2014.
- 32 funds opened new Immunic positions in Q2 2014 and 0 closed out, a net change of +32 holders.
- The largest Immunic buyer in Q2 2014 was Fidelity Investments, an estimated $21.9M added.
Based on aggregated 13F filings for Q2 2014.